Spruce Biosciences, Inc. (SPRB) Net margin 2023–2024
Spruce Biosciences, Inc. (SPRB) net profit margin by fiscal year — reported net income divided by reported revenue.
-1079.9%FY2024 · since FY2023: -475.0% → -1079.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1079.9% | -605.0 pp |
| FY2023 | -475.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating marginSPRB Operating cash flowSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →